61. Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction. (May 2008) Authors: Rumbaugh, Jeffrey A; Steiner, Joseph; Sacktor, Ned; Nath, Avindra Journal: Future HIV therapy Issue: Volume 2:Number 3(2008) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. Different disease progression rate according to HIV-1 subtype. (July 2008) Authors: de Mendoza, Carmen; Garrido, Carolina Journal: Future HIV therapy Issue: Volume 2:Number 4(2008) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Disappointment over cancelled vaccine trial. (November 2007) Journal: Future HIV therapy Issue: Volume 1:Number 4(2007) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Drug resistance differences among HIV types and subtypes: a growing problem. (November 2008) Authors: Soares, Marcelo A Journal: Future HIV therapy Issue: Volume 2:Number 6(2008) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Effect of host genetic variation on the pharmacokinetics and clinical response of NNRTIs. (January 2008) Authors: Saitoh, Akihiko; Spector, Stephen A Journal: Future HIV therapy Issue: Volume 2:Number 1(2008) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Effect of maternal HIV infection on measles susceptibility during early infancy: implications for optimizing protection of the infant. Issue 4 (July 2010) Authors: Kruczek, Alexis; Cutland, Clare; Madhi, Shabir A Journal: HIV therapy Issue: Volume 4:Issue 4(2010) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1. Issue 1 (January 2009) Authors: Rossotti, Roberto; Rusconi, Stefano Journal: HIV therapy Issue: Volume 3:Issue 1(2009) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. Elvitegravir: an emerging HIV integrase inhibitor. (September 2008) Authors: Shimura, Kazuya; Kodama, Eiichi Journal: Future HIV therapy Issue: Volume 2:Number 5(2008) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. Estimates of global HIV prevalence reduced. (January 2008) Journal: Future HIV therapy Issue: Volume 2:Number 1(2008) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. Ethics in preventive HIV vaccine research. Issue 3 (May 2009) Authors: Macklin, Ruth Journal: HIV therapy Issue: Volume 3:Issue 3(2009) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗